Dextenza With ILUX for Treatment of MGD

Clinical trial NCT04658927 · COMPLETED

Trial details

NCT number: NCT04658927
Sponsor: Warrenville Eyecare
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Meibomian Gland Dysfunction Evaporative Dry Eye

Start date: 2021-01-04
Primary completion: 2021-01-11
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.